125404-24-2

Basic information

• Product Name: 2-(3-hydroxy-2,2-dimethylpropyl)-1H-isoindole-1,3(2H)-dione
• Synonyms: 2-(3-hydroxy-2,2-dimethylpropyl)-1H-isoindole-1,3(2H)-dione;1H-isoindole-1,3(2H)-dione, 2-(3-hydroxy-2,2-dimethylpropyl)-;1H-isoindole-1,3(2H)-dione, 2-(3-hydroxy-2,2-dimethylpropy
• CAS NO: 125404-24-2
• Molecular Formula: C13H15NO3
• Molecular Weight: 233
• Mol File: 125404-24-2.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-(3-hydroxy-2,2-dimethylpropyl)-1H-isoindole-1,3(2H)-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3-hydroxy-2,2-dimethylpropyl)-1H-isoindole-1,3(2H)-dione(125404-24-2)
• EPA Substance Registry System: 2-(3-hydroxy-2,2-dimethylpropyl)-1H-isoindole-1,3(2H)-dione(125404-24-2)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 125404-24-2(Hazardous Substances Data)

Usage

General Description

2-(3-hydroxy-2,2-dimethylpropyl)-1H-isoindole-1,3(2H)-dione is a chemical compound with the molecular formula C14H17NO3. It is a derivative of isoindole-1,3(2H)-dione and contains a hydroxy group and a 2,2-dimethylpropyl group. 2-(3-hydroxy-2,2-dimethylpropyl)-1H-isoindole-1,3(2H)-dione may have potential medicinal properties due to its structural features, and it could potentially be used in the development of pharmaceutical drugs. Additionally, it may also have applications in other industries, such as materials science or agriculture. Further research and investigation into the properties and potential uses of this compound are needed to fully understand its capabilities.

Upstream product

• 40894-00-6 3-bromo-2,2-dimethyl-propan-1-ol 
• 1074-82-4 potassium phtalimide 

Relevant articles and documents

SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES

The invention relates to novel compounds according to formula Ia and Ib; (Formula Ia and Ib) wherein A represents substituted or unsubstituted C1-10heteroaryl, C6-14aryl or C6- 10heterocycloalkylaryl; R1 is C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6hydroxyalkyl, C1-6haloalkyl, C1-6amino, C3-6 cycloalkyl, or C1-6heterocycloalkyl, each of which are optionally substituted; X represents -CR3R4-(CR5R6)n-(CR7=CR8)m-(C6-14aryl)r-(C1-10heteroaryl)s-(CR9R10)p- (CR11 = CR12)q, R2 represents C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6hydroxyalkyl, C1-6haloalkyl, C1-6amino, C1-12alkylsilyl, C6-30alkylarylsilyl, C1-10heteroaryl, C6-14aryl, C1-10heterocycloalkyl, C1-10heterocycloalkenyl, C1-8cycloalkyl, C1-18cycloalkenyl, each of which is optionally substituted, or R2 represents hydrogen, carboxy, or hydroxy; or a pharmaceutically acceptable salt, solvate, or ester thereof; to processes for the preparation thereof, to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, wherein said compounds being useful, e.g. in the treatment of diseases associated with disturbances of CaSR activity, such as hyperparathyroidism.